Intravitreal Avastin in Proliferative Retinopathies

计划入组 100 人 · 首次发布于 2007 年 11 月 27 日

Natural History of Eye Diseases Related to ABCA4 Mutations

计划入组 68 人 · 首次发布于 2012 年 11 月 29 日

Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab

计划入组 150 人 · 首次发布于 2008 年 10 月 21 日

recombinant thrombomodulin domain 1 (corneal chemical burn/ocular neovascular disease)

Brolucizumab(Beovu)

Pegaptanib

Optiva Inc

Australia

Provascular GmbH

Germany

IVASCULAR CLINICA MEDICA VASCULAR E ENDOVASCULAR LTDA

Brazil

EMA Grants First-Ever Orphan Drug Designation for Radiation Maculopathy Treatment

Faricimab Demonstrates Efficacy in Treatment-Naïve Neovascular AMD Patients

Ocugen's OCU410ST Receives Orphan Drug Designation from EMA for ABCA4 Retinopathies